lemons

Studies have not established the effect of lemons on breast cancer

Lemons (Citrus limon) are a good source of vitamin C. Lemons are also a dietary source of chlorogenic acid, limonin, diosmin, hesperetin, hesperidin, eriocitrin and γ-terpinene, all of which have been reported to have anti-cancer properties. Lemons have been shown to have antioxidant, anti-inflammatory and antimicrobial properties. Consumption of lemons and lemon juice may improve cholesterol profile and reduce blood pressure. Hesperidin has been shown to inhibit androgen-dependent prostate cancer cell growth and to have chemopreventive action against carcinogen-induced lung cancer in mice. Limonin has been shown to suppression colon carcinogenesis in rats. Lemon consumption has been found to be associated with lower risk of thyroid cancer.

Lemon peel contains the monoterpene D-limonene, which is metabolized into perillic acid and some other components. D-limonene has been used in patients to dissolve cholesterol-containing gallstones and for the relief of heartburn and gastroesophageal reflux (GERD). D-limonene and its metabolites have been shown to inhibit the growth of human leukemia and lung cancer cells in the laboratory, as well as opposing lymphoma and skin, stomach, pancreatic, colon, and liver cancer in animals. D-limonene has been shown to enhance the antitumor effect of the chemotherapy drug docetaxel against prostate cancer cells without being toxic to normal prostate cells. Perillyl alcohol has been shown to inhibit androgen-induced prostate cancer cell growth and carcinogen-induced colon cancer in rats. Consumption of lemon peel has been found to be associated with lower risk of squamous cell carcinoma of the skin.

Breast cancer-related effects of eating lemons

Perillyl alcohol, hesperidin and limonin have all been shown to inhibit the proliferation of breast cancer cells in the laboratory. Lemon extract has been shown to induce apoptosis (programmed cell death) of hormone receptor positive (ER+/PR+) breast cancer cells. D-limonene, which is a fat-soluble compound, has been shown to accumulate in breast tissue in levels much higher than levels in the systemic circulation, thus potentially impacting breast cancer risk. However, a phase II clinical trial of perillyl alcohol (an important D-limonene metabolite) in the treatment of advanced breast cancer reported in 2008 that there was no benefit for the treatment. No population studies have been performed that directly assess the association between consuming lemons or lemon rind and the risk of breast cancer.

Additional comments

Non-organic lemons may be waxed and therefore should be washed thoroughly before using to prevent a transfer of pesticides and other contaminants to the flesh during cutting.

Fresh lemonade has been shown to be a good source of D-limonene.

Tags: D-limonene, Taxotere, androgens, chemotherapy, docetaxel, inflammation, lemons, perillylAlcohol, proliferation, taxanes, vitaminC

Selected breast cancer studies
+ Show study summaries

The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7 Evaluation of chemopreventive and cytotoxic effect of lemon seed extracts on human breast cancer (MCF-7) cells Naringenin reduces lung metastasis in a breast cancer resection model Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7 Activities of Ten Essential Oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 Cancer Cells Hesperidin suppressed proliferations of both Human breast cancer and androgen-dependent prostate cancer cells d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer Naringenin inhibits cell growth and migration in human breast cancer cell lines Hesperetin Induced G1-Phase Cell Cycle Arrest in Human Breast Cancer MCF-7 Cells: Involvement of CDK4 and p21 Mammary Carcinomas Induced in Human c-Ha-ras Proto-oncogene Transgenic Rats Are Estrogen-independent, but Responsive to d-Limonene Treatment Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation Perillyl Alcohol Inhibits Human Breast Cancer Cell Growth in vitro and in vivo Antioxidant and antiproliferative activities of common fruits



Breast cancer resources | Selected supplements and vitamins | Privacy policy | Search | Disclaimer/about us | Free newsletter/Donate | Sitemap